Jump Financial’s AC Immune ACIU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.3K Buy
24,064
+12,939
+116% +$35.6K ﹤0.01% 1939
2026
Q1
$30.6K Buy
+11,125
New +$34.5K ﹤0.01% 1802
2024
Q4
Sell
-12,000
Closed -$45.4K 1586
2024
Q3
$45.4K Sell
12,000
-29,321
-71% -$102K ﹤0.01% 1558
2024
Q2
$165K Buy
+41,321
New +$137K ﹤0.01% 1585
2022
Q1
Sell
-32,400
Closed -$160K 1502
2021
Q4
$160K Buy
32,400
+800
+3% +$4.65K 0.01% 1153
2021
Q3
$212K Buy
+31,600
New +$226K 0.02% 843

Other funds holding ACIU

Jump Financial's ACIU Position: Q2 2026 in Review

Jump Financial increased its AC Immune (ACIU) stake by 116% in Q2 2026, buying an estimated $35.6K and bringing the position to 24,064 shares worth $57.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1939.

Jump Financial first reported a position in ACIU in Q3 2021 and has held it in 6 quarters since. The position peaked at $212K in Q3 2021. 43 funds tracked by Wall St. Rank hold ACIU as of Q2 2026.

  • Jump Financial held 24,064 shares of AC Immune worth $57.3K as of Q2 2026.
  • Jump Financial bought 12,939 AC Immune shares in Q2 2026, an estimated $35.6K.
  • AC Immune made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1939 holding.
  • Jump Financial first reported a position in AC Immune in Q3 2021 and has held it in 6 quarters since.
  • Jump Financial's AC Immune position peaked at $212K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held AC Immune as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.